摘要
目的:评价18FDG-PET诊断卵巢癌治疗后复发的价值。方法:对54例临床疑有复发的卵巢癌患者进行了18FDG-PET全身及腹部成像,并与CT进行比较。结果:54例临床疑有复发的卵巢癌患者中,病理证实肿瘤复发35例.18FDG-PET检查39/54例显示阳性;CT常规影像检查28/54例阳性。PET、CT监测卵巢癌复发和转移的灵敏度、特异性和准确性分别为100%、78.95%和92.59%;74.29%;89.47%和79.63%。结论:18FDG-PET全身显像作为无创伤性检查技术,能及时探测到复发或扩散肿瘤的代谢变化,可以为卵巢癌术后随访提供一种有效的非侵入性影像学诊断方法。
Objective： To assess the value of 2-[fluorine-18] fluoro-2-deoxy-D-glucose （FDG） positron emission tomography （PET） of the recurrent ovarian cancer. Methods： 54 patients with ovarian cancer surgical resected had undergone PET and CT assessment. Results： 35 cases of 54 patients were proved recurrentence by pathology. 39 patients were positive detected by PET, 28 patients were positive detected by CT. The sensitivity, specificity and accuracy of PET. CT imaging for detection of recurren and metastatic ovarian cancer were 100%. 78.95% and 92.59%; 74.29%; 89.47% and 79.63%. Conclusion：FDG-PET has showed important value in the diagnosis of ovarian cancer recurred.
出处
《中国伤残医学》
2007年第3期24-25,共2页
Chinese Journal of Trauma and Disability Medicine
